Refine your search with our Advanced Search Tool
Listing contains 128 trial(s)
Colon Cancer
Phase III
A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer Study Number: 04-176 |
Prevention study
Physicans Encouraging Colorectal Screening (PECS) Study Number: 02-017 |
Quality of Life Study
An Intervention to Improve End-of-Life Symptom Distress. Study Number: 02-126 |
Registry
The Hereditary Colorectal Tumor Registry Study Number: 04-112 |
Extrahepatic Bile Duct Cancer
Lab
Investigation of the Immune Response to Gastrointestional Tumors and Development of Novel biomarkers for the Presence of Gastrointestional Cancer. Study Number: 02-077 |
Gastrointestinal Stromal Tumor (GIST)
Registry
The Surgical Gastrointestinal Diseases Registry Study Number: 03-145 |
Pancreatic Cancer
Tissue and/or blood banking study
Tissue and Fluid Banking for the University of Pittsburgh Gastrointestinal Cancer Tissue Bank Study Number: 97-131 |
Pancreatic Cancer Biospecimen Repository Study Number: 08-039 |
Rectal Cancer
Registry
The Hereditary Colorectal Tumor Registry Study Number: 04-112 |
About This Web Site
|
Give Us Your Feedback
|
Privacy Statement
|
Disclaimer
|
Informatics Web Resources
©
UPMC, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
412-647-2811
|
PCI-INFO@upmc.edu
|
Send questions and comments to UPCIwebupdates@upmc.edu
